Latest Articles
(PDF) Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment - ResearchGate
(PDF) Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment ResearchGate
Published: Jan. 25, 2025, 1:07 p.m.
€26.5M Series B Funding pushes Swedish company's endometriosis therapy to next stage - ArcticStartup - ArcticStartup
€26.5M Series B Funding pushes Swedish company's endometriosis therapy to next stage - ArcticStartup ArcticStartup
Published: Jan. 24, 2025, 12:51 p.m.
€26.5M Series B funding pushes Swedish company's endometriosis therapy to next stage - ArcticStartup - ArcticStartup
€26.5M Series B funding pushes Swedish company's endometriosis therapy to next stage - ArcticStartup ArcticStartup
Published: Jan. 24, 2025, 12:51 p.m.
Does Chemoradiotherapy Boost Survival in Endometrial Cancer? - Medscape
Does Chemoradiotherapy Boost Survival in Endometrial Cancer? Medscape
Published: Jan. 21, 2025, 9:45 a.m.
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer - Indian Pharma Post
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer Indian Pharma Post
Published: Jan. 21, 2025, 4:36 a.m.
Personalizing Radiotherapy for Endometrial Cancer: Balancing Innovation and Quality of Life - Journal of Clinical Pathways
Personalizing Radiotherapy for Endometrial Cancer: Balancing Innovation and Quality of Life Journal of Clinical Pathways
Published: Jan. 17, 2025, 2:21 p.m.
Ortho-pelvic physical therapy and it’s benefits - WFLA
Ortho-pelvic physical therapy and it’s benefits WFLA
Published: Jan. 15, 2025, 10:02 p.m.
Editorial: Advances in the Pharmacotherapy of Chronic Pelvic Pain Conditions - Frontiers
Editorial: Advances in the Pharmacotherapy of Chronic Pelvic Pain Conditions Frontiers
Published: Jan. 14, 2025, 10:43 a.m.
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer - «Кавказ Пост» - новости Северного Кавказа и Закавказья
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer «Кавказ Пост» - новости Северного Кавказа и Закавказья
Published: Jan. 12, 2025, 2:45 a.m.
A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma - Nature.com
A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma Nature.com
Published: Jan. 9, 2025, 7:28 a.m.
Link copied to clipboard!